Infinity Pharmaceuticals | INFI - Sales Revenues


Infinity Pharmaceuticals reported $583K in Sales Revenues for its fiscal quarter ending in June of 2023.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Amgen USD 9.9B 340M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Cipla INR 75.18B 710M Dec/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 67.33M 65.44M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Eisai JPY 219.94B 22.58B Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Grifols EUR 2.34B 33.3M Mar/2026
Incyte USD 1.51B 140M Dec/2025
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Ionis Pharmaceuticals USD 203M 46M Dec/2025
J&J USD 24.6B 610M Dec/2025
Novartis USD 13.86B 50M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
Plus Therapeutics USD 1.37M 30K Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
TG Therapeutics USD 192.57M 30.87M Dec/2025